An overview of rational design of mRNA-based therapeutics and vaccines

Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129 · see citing works

mRNA vaccines — a new era in vaccinology

Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667 · see citing works

Direct Gene Transfer into Mouse Muscle in Vivo

Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173 · see citing works

The codon adaptation index-a measure of directional synonymous codon usage bias, and its potential applications

Sharp, P. M., & Li, W.-H. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.3.1281 · Cited by 3,992 · see citing works

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888 · see citing works

Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets

Sonenberg, N., & Hinnebusch, A. G. (2009) · Cell · doi:10.1016/j.cell.2009.01.042 · Cited by 3,304 · see citing works

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,237 · cited 2× · see citing works

Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728 · see citing works

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA

Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662 · see citing works

mRNA-based therapeutics--developing a new class of drugs

Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474 · see citing works

Synonymous but not the same: the causes and consequences of codon bias

Plotkin, J. B., & Kudla, G. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2899 · Cited by 1,677 · see citing works

RNA‐binding proteins and post‐transcriptional gene regulation

Glisovic, T., Bachorik, J. L., Yong, J., & Dreyfuss, G. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.03.004 · Cited by 1,398 · see citing works

Codon bias and heterologous protein expression

Gustafsson, C., Govindarajan, S., & Minshull, J. (2004) · Trends in Biotechnology · doi:10.1016/j.tibtech.2004.04.006 · Cited by 1,330 · see citing works

Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery

Kowalski, P. S., Rudra, A., Miao, L., & Anderson, D. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.012 · Cited by 1,127 · see citing works

Translational control by 5′-untranslated regions of eukaryotic mRNAs

Hinnebusch, A. G., Ivanov, I. P., & Sonenberg, N. (2016) · Science · doi:10.1126/science.aad9868 · Cited by 1,079 · see citing works

DNA vaccines: ready for prime time?

Kutzler, M. A., & Weiner, D. B. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2432 · Cited by 1,077 · see citing works

Reversible methylation of m6Am in the 5′ cap controls mRNA stability

Mauer, J., Luo, X., Blanjoie, A., Jiao, X., Grozhik, A. V., Patil, D. P., Linder, B., Pickering, B. F., Vasseur, J., Chen, Q., et al. (2016) · Nature · doi:10.1038/nature21022 · Cited by 1,072 · see citing works

mRNA is an endogenous ligand for toll-like receptor 3

Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062 · see citing works

AU-rich elements and associated factors: are there unifying principles?

Barreau, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki1012 · Cited by 1,033 · see citing works

RNA-Based Therapeutics: Current Progress and Future Prospects

Burnett, J., & Rossi, J. J. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.12.008 · Cited by 910 · see citing works

Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA

Karikó, K., Muramatsu, H., Ludwig, J., & Weissman, D. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr695 · Cited by 898 · see citing works

mRNA capping: biological functions and applications

Ramanathan, A., Robb, G. B., & Chan, S. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw551 · Cited by 892 · see citing works

Tools for translation: non-viral materials for therapeutic mRNA delivery

Hajj, K. A., & Whitehead, K. A. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.56 · Cited by 799 · see citing works

Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation

Anderson, B. R., Muramatsu, H., Nallagatla, S. R., Bevilacqua, P. C., Sansing, L. H., Weissman, D., & Karikó, K. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq347 · Cited by 682 · see citing works

Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses

Bahl, K., Senn, J. J., Yuzhakov, O., Bulychev, A., Brito, L. A., Hassett, K. J., Laska, M. E., Smith, M., Almarsson, Ö., Thompson, J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.035 · Cited by 642 · see citing works

Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells

Holtkamp, S., Kreiter, S., Selmi, A., Simon, P., Koslowski, M., Huber, C., Türeci, O., & Sahin, U. (2006) · Blood · doi:10.1182/blood-2006-04-015024 · Cited by 625 · see citing works

T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans

Maus, M. V., Haas, A. R., Beatty, G. L., Albelda, S. Μ., Levine, B. L., Liu, X., Zhao, Y., Kalos, M. D., & June, C. H. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0006 · Cited by 586 · see citing works

Opportunities and Challenges in the Delivery of mRNA-Based Vaccines

Wadhwa, A., Aljabbari, A., Lokras, A., Foged, C., & Thakur, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020102 · Cited by 584 · see citing works

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

Heiser, A., Coleman, D., Dannull, J., Yancey, D., Maurice, M. A., Lallas, C. D., Dahm, P., Niedzwiecki, D., Gilboa, E., & Vieweg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214364 · Cited by 562 · see citing works

Ligand-targeted liposome design: challenges and fundamental considerations

Noble, G. T., Stefanick, J. F., Ashley, J. D., Kiziltepe, T., & Bilgiçer, B. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.09.007 · Cited by 546 · see citing works

Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals

Thess, A., Grund, S., Mui, B. L., Hope, M. J., Baumhof, P., Fotin-Mleczek, M., & Schlake, T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.103 · Cited by 513 · cited 1× · see citing works

mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases

Maruggi, G., Zhang, C., Li, J., Ulmer, J. B., & Yu, D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.020 · Cited by 507 · see citing works

The requirement for eukaryotic initiation factor 4A (eIF4A) in translation is in direct proportion to the degree of mRNA 5′ secondary structure

Svitkin, Y. V., Pause, A., Haghighat, A., Pyronnet, S., Witherell, G. W., Belsham, G. J., & Sonenberg, N. (2001) · RNA · doi:10.1017/s135583820100108x · Cited by 477 · see citing works

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA

Nair, S. K., Boczkowski, D., Morse, M., Cumming, R. I., Lyerly, H. K., & Gilboa, E. (1998) · Nature Biotechnology · doi:10.1038/nbt0498-364 · Cited by 398 · see citing works

Deconvoluting Lipid Nanoparticle Structure for Messenger RNA Delivery

Eygeris, Y., Patel, S., Jozić, A., & Sahay, G. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c01386 · Cited by 382 · see citing works

Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response

Linares-Fernández, S., Lacroix, C., Exposito, J.-Y., & Verrier, B. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.10.002 · Cited by 376 · see citing works

The IRP/IRE system in vivo: insights from mouse models

Wilkinson, N., & Pantopoulos, K. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00176 · Cited by 366 · see citing works

Structural basis for m7G recognition and 2′-O-methyl discrimination in capped RNAs by the innate immune receptor RIG-I

Devarkar, S. C., Wang, C., Miller, M. T., Ramanathan, A., Jiang, F., Khan, A. G., Patel, S. S., & Marcotrigiano, J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515152113 · Cited by 357 · see citing works

Untitled work

(2001) · PubMed Central · Cited by 342 · see citing works

Cancer therapy using a self-replicating RNA vaccine

Han, Y., Zaks, T. Z., Wang, R., Irvine, K. R., Kammula, U. S., Marincola, F. M., Leitner, W. W., & Restifo, N. P. (1999) · Nature Medicine · doi:10.1038/10548 · Cited by 322 · see citing works

Efficient generation of human iPSCs by a synthetic self-replicative RNA

Yoshioka, N., Gros, E., Li, H.-R., Kumar, S., Deacon, D. C., Maron, C., Muotri, A. R., Chi, N. C., Fu, X.-D., Yu, B. D., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.06.001 · Cited by 312 · see citing works

Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma

Wilgenhof, S., Corthals, J., Heirman, C., van Baren, N., Lucas, S., Kvistborg, P., Thielemans, K., & Neyns, B. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.4121 · Cited by 312 · see citing works

Balanced Codon Usage Optimizes Eukaryotic Translational Efficiency

Qian, W., Yang, J.-R., Pearson, N. M., Maclean, C. J., & Zhang, J. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002603 · Cited by 303 · see citing works

Heterologous Protein Expression Is Enhanced by Harmonizing the Codon Usage Frequencies of the Target Gene with those of the Expression Host

Angov, E., Hillier, C. J., Kincaid, R. L., & Lyon, J. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002189 · Cited by 284 · see citing works

A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids

Read, M. L., Singh, S., Ahmed, Z., Stevenson, M., Briggs, S. S., Oupický, D., Barrett, L. B., Spice, R., Kendall, M. A. F., Berry, M., et al. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni085 · Cited by 279 · see citing works

RNA therapeutics on the rise

Wang, F., Zuroske, T., & Watts, J. K. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00078-0 · Cited by 275 · see citing works

Two-Helper RNA System for Production of Recombinant Semliki Forest Virus Particles

Smerdou, C., & Liljeström, P. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1092-1098.1999 · Cited by 263 · see citing works

Novel “anti-reverse” cap analogs with superior translational properties

Jemielity, J., Fowler, T. E., Zuberek, J., Stȩpiński, J., Lewdorowicz, M., Niedźwiecka-Kornaś, A., Stolarski, R., Darżynkiewicz, E., & Rhoads, R. E. (2003) · RNA · doi:10.1261/rna.5430403 · Cited by 263 · see citing works

Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification

Vaidyanathan, S., Azizian, K. T., Haque, A. K. M. A., Henderson, J. M., Hendel, A., Shore, S., Antony, J. S., Hogrefe, R. I., Kormann, M. S. D., Porteus, M. H., et al. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2018.06.010 · Cited by 262 · see citing works

Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA

Weide, B., Carralot, J.-P., Reese, A., Scheel, B., Eigentler, T. K., Hoerr, I., Rammensee, H.-G., Garbe, C., & Pascolo, S. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31815ce501 · Cited by 261 · see citing works

Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy

Guevara, M. L., Persano, F., & Persano, S. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.589959 · Cited by 257 · see citing works

mRNA transcript therapy

Weissman, D. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.973859 · Cited by 228 · see citing works

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

Papachristofilou, A., Hipp, M., Klinkhardt, U., Früh, M., Sebastian, M., Weiß, C., Pless, M., Cathomas, R. L., Hilbe, W., Pall, G., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0520-5 · Cited by 228 · see citing works

Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients

Rittig, S. M., Haentschel, M., Weimer, K. J., Heine, A., Muller, M. R., Brugger, W., Horger, M. S., Maksimovic, O., Stenzl, A., Hoerr, I., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.289 · Cited by 226 · see citing works

RNA viruses can hijack vertebrate microRNAs to suppress innate immunity

Trobaugh, D. W., Gardner, C. L., Sun, C., Haddow, A. D., Wang, E., Chapnik, E., Mildner, A., Weaver, S. C., Ryman, K. D., & Klimstra, W. B. (2013) · Nature · doi:10.1038/nature12869 · Cited by 226 · see citing works

Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo

Kuhn, A. N., Diken, M., Kreiter, S., Selmi, A., Kowalska, J., Jemielity, J., Darzynkiewicz, E., Huber, C., Türeci, Ö., & Sahin, U. (2010) · Gene Therapy · doi:10.1038/gt.2010.52 · Cited by 226 · see citing works

5’-triphosphate-dependent activation of PKR by RNAs with short stem-loops

Nallagatla, S. R., Hwang, J., Toroney, R., Zheng, X., Cameron, C. E., & Bevilacqua, P. C. (2007) · Science · doi:10.1126/science.1147347 · Cited by 222 · see citing works

A trans-amplifying RNA vaccine strategy for induction of potent protective immunity

Beissert, T., Perkovic, M., Vogel, A., Erbar, S., Walzer, K. C., Hempel, T., Brill, S., Haefner, E., Becker, R., Türeci, Ö., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.09.009 · Cited by 212 · see citing works

Current prospects for mRNA gene delivery

Yamamoto, A., Kormann, M., Rosenecker, J., & Rudolph, C. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.016 · Cited by 193 · see citing works

Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation

Coolen, A.-L., Lacroix, C., Mercier‐Gouy, P., Delaune, E. A., Monge, C., Exposito, J., & Verrier, B. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.12.019 · Cited by 192 · see citing works

RNA: The new revolution in nucleic acid vaccines

Geall, A. J., Mandl, C. W., & Ulmer, J. B. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.05.001 · Cited by 187 · see citing works

RNA 2′-O-Methylation (Nm) Modification in Human Diseases

Dimitrova, D. G., Teysset, L., & Carré, C. (2019) · Genes · doi:10.3390/genes10020117 · Cited by 187 · see citing works

A Viral RNA Structural Element Alters Host Recognition of Nonself RNA

Hyde, J., Gardner, C. L., Kimura, T., White, J. P., Gai, L., Trobaugh, D. W., Huang, C., Tonelli, M., Paessler, S., Takeda, K., et al. (2014) · Science · doi:10.1126/science.1248465 · Cited by 179 · see citing works

mRNA-Based Protein Replacement Therapy for the Heart

Magadum, A., Kaur, K., & Zangi, L. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.11.018 · Cited by 176 · see citing works

Modulation of mRNA stability as a novel therapeutic approach

Eberhardt, W., Doller, A., Akool, E.-S., & Pfeilschifter, J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.01.002 · Cited by 173 · see citing works

Chemical Modifications to RNA: A New Layer of Gene Expression Regulation

Song, J., & Yi, C. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b00960 · Cited by 167 · see citing works

Synonymous codon usage influences the local protein structure observed

Saunders, R., & Deane, C. M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq495 · Cited by 165 · see citing works

MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct

Jain, R., Frederick, J. P., Huang, E. Y., Burke, K. E., Mauger, D. M., Andrianova, E. A., Farlow, S. J., Siddiqui, S., Pimentel, J., Cheung-Ong, K., et al. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0734 · Cited by 164 · see citing works

Multiparameter RNA and Codon Optimization: A Standardized Tool to Assess and Enhance Autologous Mammalian Gene Expression

Fath, S., Bauer, A. P., Liss, M. A., Spriestersbach, A., Maertens, B., Hahn, P. F., Ludwig, C., Schäfer, F., Graf, M., & Wagner, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017596 · Cited by 158 · see citing works

A tale of non-canonical tails: gene regulation by post-transcriptional RNA tailing

Yu, S., & Kim, V. N. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0246-8 · Cited by 142 · see citing works

Eukaryotic translation initiation: there are (at least) two sides to every story.

Sachs, A. B., & Varani, G. (2000) · Nature Structural Biology · doi:10.1038/75120 · Cited by 141 · see citing works

The promise of nucleic acid vaccines

Restifo, N. P., Ying, H., Hwang, L. N., & Leitner, W. W. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301117 · Cited by 136 · see citing works

Decoding mechanisms by which silent codon changes influence protein biogenesis and function

Bali, V., & Bebok, Z. M. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.03.011 · Cited by 133 · see citing works

Tumor vaccination using messenger RNA: prospects of a future therapy

Kreiter, S., Diken, M., Selmi, A., Türeci, Ö., & Şahin, U. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.03.007 · Cited by 120 · see citing works

A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs

Kallen, K., & Theß, A. (2013) · Therapeutic Advances in Vaccines · doi:10.1177/2051013613508729 · Cited by 120 · see citing works

Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases

Trepotec, Z., Lichtenegger, E., Plank, C., Aneja, M. K., & Rudolph, C. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.12.012 · Cited by 115 · see citing works

Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy

Youn, H., & Chung, J.-K. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1057563 · Cited by 114 · see citing works

Synthetic mRNA capping

Muttach, F., Muthmann, N., & Rentmeister, A. (2017) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.13.274 · Cited by 112 · see citing works

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients

Gulck, E. R. V., Vlieghe, E., Vekemans, M., Tendeloo, V. F. V., de Velde, A. V., Smits, E., Anguille, S., Cools, N., Goossens, H., Mertens, L., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834f33e8 · Cited by 111 · see citing works

Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA

Asrani, K. H., Farelli, J. D., Stahley, M. R., Miller, R. L., Cheng, C. J., Subramanian, R. R., & Brown, J. M. (2018) · RNA Biology · doi:10.1080/15476286.2018.1450054 · Cited by 111 · see citing works

IFIT1 Differentially Interferes with Translation and Replication of Alphavirus Genomes and Promotes Induction of Type I Interferon

Reynaud, J. M., Kim, D., Atasheva, S., Aliaksandra, R., White, J. P., Diamond, M., Weaver, S. C., Frolova, E. I., & Frolov, I. V. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004863 · Cited by 109 · see citing works

The 5′ and 3′ ends of alphavirus RNAs – Non-coding is not non-functional

Hyde, J., Chen, R., Trobaugh, D. W., Diamond, M., Weaver, S. C., Klimstra, W. B., & Wilusz, J. (2015) · Virus Research · doi:10.1016/j.virusres.2015.01.016 · Cited by 105 · see citing works

Phase I clinical trial of an intranodally administered mRNA-based therapeutic vaccine against HIV-1 infection

Leal, L., Guardo, A. C., Morón‐López, S., Salgado, M., Mothe, B., Heirman, C., Pannus, P., Vanham, G., van den Ham, H., Gruters, R. A., et al. (2018) · AIDS · doi:10.1097/qad.0000000000002026 · Cited by 100 · see citing works

mRNA-Based Genetic Reprogramming

Warren, L. A., & Lin, C. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.12.009 · Cited by 91 · see citing works

mRNA: A Novel Avenue to Antibody Therapy?

Schlake, T., Thran, M., Fiedler, K., Heidenreich, R., Petsch, B., & Fotin‐Mleczek, M. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.03.002 · Cited by 90 · see citing works

Versatile Trans-Replication Systems for Chikungunya Virus Allow Functional Analysis and Tagging of Every Replicase Protein

Utt, A., Quirin, T., Saul, S., Hellström, K., Ahola, T., & Merits, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151616 · Cited by 83 · see citing works

2'-O-methylation of the mRNA cap protects RNAs from decapping and degradation by DXO

Picard‐Jean, F., Brand, C., Tremblay-Létourneau, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193804 · Cited by 80 · see citing works

Precise tuning of disulphide crosslinking in mRNA polyplex micelles for optimising extracellular and intracellular nuclease tolerability

Dirisala, A., Uchida, S., Tockary, T. A., Yoshinaga, N., Li, J., Osawa, S., Gorantla, L., Fukushima, S., Osada, K., & Kataoka, K. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1550646 · Cited by 76 · see citing works

Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond

Vallazza, B., Petri, S., Poleganov, M. A., Eberle, F., Kuhn, A. N., & Şahin, U. (2015) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1288 · Cited by 73 · see citing works

Effective delivery with enhanced translational activity synergistically accelerates mRNA-based transfection

Zohra, F. T., Chowdhury, E. H., Tada, S., Hoshiba, T., & Akaike, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.059 · Cited by 71 · see citing works

In vitro evolution of enhanced RNA replicons for immunotherapy

Li, Y., Teague, B., Zhang, Y., Su, Z., Porter, E., Dobosh, B., Wagner, T., Irvine, D. J., & Weiss, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-43422-0 · Cited by 71 · see citing works

Self-Replicating RNA Viruses for RNA Therapeutics

Lundstrom, K. H. (2018) · Molecules · doi:10.3390/molecules23123310 · Cited by 65 · see citing works

Investigation of charge ratio variation in mRNA – DEAE-dextran polyplex delivery systems

Siewert, C., Haas, H., Nawroth, T., Ziller, A., Nogueira, S. S., Schroer, M. A., Blanchet, C. E., Svergun, D. I., Rădulescu, A., Bates, F., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.020 · Cited by 63 · see citing works

Design, Assembly, Production, and Transfection of Synthetic Modified mRNA

Oh, S., & Kessler, J. A. (2018) · Methods · doi:10.1016/j.ymeth.2017.10.008 · Cited by 58 · see citing works

Optimized transfection of mRNA transcribed from a d(A/T)100 tail-containing vector

Elango, N., Elango, S., Shivshankar, P., & Katz, M. S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.067 · Cited by 57 · see citing works

Modified ARCA analogs providing enhanced translational properties of capped mRNAs

Kocmik, I., Piecyk, K., Rudzińska, M., Niedźwiecka-Kornaś, A., Darżynkiewicz, E., Grzela, R., & Jankowska‐Anyszka, M. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1486164 · Cited by 57 · see citing works

Self-Replicating RNA

Tews, B. A., & Meyers, G. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6481-9_2 · Cited by 54 · see citing works

Scaffold-mediated delivery for non-viral mRNA vaccines

Chen, R., Zhang, H., Yan, J., & Bryers, J. D. (2018) · Gene Therapy · doi:10.1038/s41434-018-0040-9 · Cited by 50 · see citing works

Structural components for amplification of positive and negative strand VEEV splitzicons

Blakney, A. K., McKay, P. F., & Shattock, R. J. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00071 · Cited by 47 · see citing works

A Chikungunya Virus trans -Replicase System Reveals the Importance of Delayed Nonstructural Polyprotein Processing for Efficient Replication Complex Formation in Mosquito Cells

Bartholomeeusen, K., Utt, A., Coppens, S., Rausalu, K., Vereecken, K., Ariën, K. K., & Merits, A. (2018) · Journal of Virology · doi:10.1128/jvi.00152-18 · Cited by 44 · see citing works

mRNA transfection by a Xentry-protamine cell-penetrating peptide is enhanced by TLR antagonist E6446

Bell, G. D., Yang, Y., Leung, E. Y., & Krissansen, G. W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201464 · Cited by 43 · see citing works

5′-UTR recruitment of the translation initiation factor eIF4GI or DAP5 drives cap-independent translation of a subset of human mRNAs

Haizel, S. A., Bhardwaj, U., Gonzalez, R. L., Mitra, S., & Goss, D. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013678 · Cited by 43 · see citing works

Towards mRNA with superior translational activity: synthesis and properties of ARCA tetraphosphates with single phosphorothioate modifications

Strenkowska, M., Kowalska, J., Łukaszewicz, M., Zuberek, J., Su, W., Rhoads, R. E., Darżynkiewicz, E., & Jemielity, J. (2010) · New Journal of Chemistry · doi:10.1039/b9nj00644c · Cited by 42 · see citing works

Messenger RNA- Versus Retrovirus-Based Induced Pluripotent Stem Cell Reprogramming Strategies: Analysis of Genomic Integrity

Steichen, C., Luce, E., Maluenda, J., Tosca, L., Moreno, I., Desterke, C., Dianat, N., Goulinet, S., Awan-Toor, S., Burks, D. J., et al. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0158 · Cited by 39 · see citing works

An RNA trapping mechanism in Alphavirus mRNA promotes ribosome stalling and translation initiation

Toribio, R., Díaz‐López, I., Boskovic, J., & Ventoso, I. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw172 · Cited by 39 · see citing works

Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix

de Jong, W., Leal, L., Buyze, J., Pannus, P., Guardo, A. C., Salgado, M., Mothe, B., Moltó, J., Morón‐López, S., Gálvez, C., et al. (2019) · Vaccines · doi:10.3390/vaccines7040209 · Cited by 37 · see citing works

mRNA Post-Transcriptional Regulation by AU-Rich Element-Binding Proteins in Liver Inflammation and Cancer

Dolicka, D., Sobolewski, C., de Sousa, M. C., Gjorgjieva, M., & Foti, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186648 · Cited by 34 · see citing works

Recognition of Poly(A) RNA through Its Intrinsic Helical Structure

Tang, T. T. L., & Passmore, L. A. (2019) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2019.84.039818 · Cited by 29 · see citing works

Transferrin-Lipoplexes with Protamine-Condensed DNA for Serum-Resistant Gene Delivery

de Ilarduya, C. T., Arangoa, M. A., & Düzgüneş, N. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)73022-5 · Cited by 26 · see citing works

Strategies for modulating innate immune activation and protein production of in vitro transcribed mRNAs

Loomis, K. H., Kirschman, J. L., Bhosle, S. M., Bellamkonda, R. V., & Santangelo, P. J. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01753j · Cited by 24 · see citing works

In Vivo and In Vitro Analysis of Poly(A) Length Effects on mRNA Translation

Peng, J., Murray, E. L., & Schoenberg, D. R. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-033-1_15 · Cited by 23 · see citing works

The use of β-cell transcription factors in engineering artificial β cells from non-pancreatic tissue

Gerace, D., Martiniello-Wilks, R., O'Brien, B., & Simpson, A. (2014) · Gene Therapy · doi:10.1038/gt.2014.93 · Cited by 23 · see citing works

Leap-In Transposases and Transposons Accelerate Cell Line Development

Lee, M., Sepulveda, C., Tang, C., Truong, V., Vavilala, D. T., Webster, L., Zhang, B., & Boldog, F. L. (2019) · Genetic Engineering & Biotechnology News · doi:10.1089/gen.39.09.18 · Cited by 10 · see citing works

RNA Epitranscriptome: Role of the 5' Cap

McCaffrey, A. P. (2019) · Genetic Engineering & Biotechnology News · doi:10.1089/gen.39.05.17 · Cited by 9 · see citing works

The SERRATE protein is involved in alternative splicing in Arabidopsis thaliana

Raczyńska, K. D., Stępień, A., Kierzkowski, D., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa045 · Cited by 5 · see citing works

Advances in COVID-19 mRNA vaccine development

Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00950-y · Cited by 601 · see citing works

Aggregation and Immunogenicity of Therapeutic Proteins

Filipe, V., Hawe, A., Schellekens, H., & Jiskoot, W. (2010) · doi:10.1002/9780470769829.ch10 · Cited by 39 · see citing works

Immunogenicity of Therapeutic Proteins

Swanson, S. J. (2010) · doi:10.1002/9780470595886.ch4 · Cited by 29 · see citing works

Immunogenicity

Galson, J. D., & O’Connor, D. (2015) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0000937

Essential biopharmaceutical properties of drugs at the gastrointestinal absorption stage (Review)

Shohin, I. E., Kulinich, Y. I., Ramenskaya, G. V., et al. (2011) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-011-0645-4 · Cited by 2 · see citing works

An overview of scientific and regulatory issues for the immunogenicity of biological products.

Chamberlain, P., & Mire‐Sluis, A. R. (2003) · PubMed · Cited by 31 · see citing works